How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study-Reference-Cited by-同舟云学术

How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study

Published:2013-03 Issue:3 Volume:90 Page:372-377
ISSN:0738-3991
Container-title:Patient Education and Counseling
language:en
Short-container-title:Patient Education and Counseling

Author:

Jenkins Nicholas,Lawton Julia,Douglas Margaret,Walker Simon,Finnie Robert,Porteous Mary,Hallowell Nina

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Clinical guidelines evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia;DeMott,2008

2. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states;Slack;Lancet,1969

3. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study;Neil;Eur Heart J,2008

4. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study;Versmissen;Brit Med J,2008

5. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study;Neil;Brit Med J,2000

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels;Frontiers in Cardiovascular Medicine;2024-07-26

2. The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia;The Journal of Clinical Endocrinology & Metabolism;2024-01-23

3. Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience;British Journal of General Practice;2022-03-24

4. Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort;Journal of Clinical Lipidology;2022-03

5. Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis;BMJ Open;2019-07